Department of Microbiology, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan.
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan.
Int J Environ Res Public Health. 2022 Aug 29;19(17):10768. doi: 10.3390/ijerph191710768.
The outbreak of coronavirus disease 2019 (COVID-19) devastated the overall health management strategy of most countries. In this scenario, the present study provided insights into the possible impact of the COVID-19 pandemic on dengue infection. This ecological study retrieved data from WHO/Government reporting system from 22 major dengue epidemic countries. Incidence of dengue infections during the pre-COVID-19 time (20152019) and COVID-19 period (20202021) was compared. A correlation between the dengue and COVID-19 cases and predicted dengue incidence in 2022 was calculated using the linear regression equation. Data indicated that dengue incidences across the studied area decreased by 16% during the pandemic period (2.73 million vs. 2.29 million; < 0.05) than the same reported in pre-COVID-19 time. Although countries in Latin America reported more cases than Asia, a positive correlation (r = 0.83) between dengue and COVID-19 cases was observed in Asia. Prediction analysis warned that specific preparation for dengue management is needed in some countries of both regions in 2022 to contain the upsurge in incidences. Due to the similar nature of symptoms of dengue and COVID-19, a state of confusion will be prevailing during the ongoing pandemic. Therefore, comprehensive and evidence-based scientific approaches were warranted at all levels.
2019 年冠状病毒病(COVID-19)的爆发使大多数国家的整体健康管理策略受到重创。在此背景下,本研究深入探讨了 COVID-19 大流行对登革热感染的可能影响。本生态研究从世界卫生组织/政府报告系统中检索了 22 个主要登革热流行国家的数据。比较了 COVID-19 前时期(2015-2019 年)和 COVID-19 时期(2020-2021 年)的登革热感染发生率。使用线性回归方程计算了登革热和 COVID-19 病例与预测的 2022 年登革热发病率之间的相关性。数据表明,大流行期间研究区域的登革热发病率下降了 16%(273 万例比 229 万例;<0.05),低于 COVID-19 前时期报告的发病率。尽管拉丁美洲国家报告的病例多于亚洲国家,但亚洲国家的登革热和 COVID-19 病例之间存在正相关关系(r = 0.83)。预测分析警告说,2022 年两个地区的一些国家需要为登革热管理做好具体准备,以遏制发病率的上升。由于登革热和 COVID-19 的症状性质相似,因此在大流行期间将普遍存在混乱状态。因此,在各个层面都需要采取全面和基于证据的科学方法。